Related references
Note: Only part of the references are listed.Inhibition of Classical and Alternative Modes of Respiration in Candida albicans Leads to Cell Wall Remodeling and Increased Macrophage Recognition
Lucian Duvenage et al.
MBIO (2019)
Twenty Years of the SENTRY Antifungal Surveillance Program: Results for Candida Species From 1997-2016
Michael A. Pfaller et al.
OPEN FORUM INFECTIOUS DISEASES (2019)
The potential of respiration inhibition as a new approach to combat human fungal pathogens
Lucian Duvenage et al.
CURRENT GENETICS (2019)
Synergistic effect of nikkomycin Z with caspofungin and micafungin against Candida albicans and Candida parapsilosis biofilms
R. Kovacs et al.
LETTERS IN APPLIED MICROBIOLOGY (2019)
FK506 Resistance of Saccharomyces cerevisiae Pdr5 and Candida albicans Cdr1 Involves Mutations in the Transmembrane Domains and Extracellular Loops
Koichi Tanabe et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Pathogenetic Impact of Bacterial-Fungal Interactions
Filomena Nogueira et al.
MICROORGANISMS (2019)
Accuracy of Sensititre YeastOne echinocandins epidemiological cut-off values for identification of FKS mutant Candida albicans and Candida glabrata: a ten year national survey of the Fungal Infection Network of Switzerland (FUNGINOS)
A. Kritikos et al.
CLINICAL MICROBIOLOGY AND INFECTION (2018)
Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline
A. J. Ullmann et al.
CLINICAL MICROBIOLOGY AND INFECTION (2018)
Biofilms and beyond: expanding echinocandin utility
Emily L. Larkin et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2018)
Invasive candidiasis
Peter C. Pappas et al.
NATURE REVIEWS DISEASE PRIMERS (2018)
Calcineurin in fungal virulence and drug resistance: Prospects for harnessing targeted inhibition of calcineurin for an antifungal therapeutic approach
Praveen R. Juvvadi et al.
VIRULENCE (2017)
Portrait of Candida Species Biofilm Regulatory Network Genes
Daniela Araujo et al.
TRENDS IN MICROBIOLOGY (2017)
The Candida albicans transcription factor Cas5 couples stress responses, drug resistance and cell cycle regulation
Jinglin L. Xie et al.
NATURE COMMUNICATIONS (2017)
Effects of Echinocandins in Combination with Nikkomycin Z against Invasive Candida albicans Bloodstream Isolates and the fks Mutants
Yuk-Yam Cheung et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Monitoring Antifungal Resistance in a Global Collection of Invasive Yeasts and Molds: Application of CLSI Epidemiological Cutoff Values and Whole-Genome Sequencing Analysis for Detection of Azole Resistance in Candida albicans
Mariana Castanheira et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Tolerance to Caspofungin in Candida albicans Is Associated with at Least Three Distinctive Mechanisms That Govern Expression of FKS Genes and Cell Wall Remodeling
Feng Yang et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
The roles of CDR1, CDR2, and MDR1 in kaempferol-induced suppression with fluconazole-resistant Candida albicans
Jing Shao et al.
PHARMACEUTICAL BIOLOGY (2016)
Chromosome 5 of Human Pathogen Candida albicans Carries Multiple Genes for Negative Control of Caspofungin and Anidulafungin Susceptibility
Sumanun Suwunnakorn et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
Peter G. Pappas et al.
CLINICAL INFECTIOUS DISEASES (2016)
Ibuprofen Potentiates the In Vivo Antifungal Activity of Fluconazole against Candida albicans Murine Infection
Sofia Costa-de-Oliveira et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Role of Echinocandins in Fungal Biofilm-Related Disease: Vascular Catheter-Related Infections, Immunomodulation, and Mucosal Surfaces
Aspasia Katragkou et al.
CLINICAL INFECTIOUS DISEASES (2015)
Defining the frontiers between antifungal resistance, tolerance and the concept of persistence
Eric Delarze et al.
DRUG RESISTANCE UPDATES (2015)
The ABCs of Candida albicans Multidrug Transporter Cdr1
Rajendra Prasad et al.
EUKARYOTIC CELL (2015)
Adhesion, biofilm formation, cell surface hydrophobicity, and antifungal planktonic susceptibility: relationship among Candida spp.
Ana Silva-Dias et al.
FRONTIERS IN MICROBIOLOGY (2015)
Efficacy and safety of echinocandins versus triazoles for the prophylaxis and treatment of fungal infections: a meta-analysis of RCTs
J. -F. Wang et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2015)
Isavuconazole, a broad-spectrum triazole for the treatment of systemic fungal diseases
Seyedmojtaba Seyedmousavi et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2015)
Modulation of Alternaria infectoria Cell Wall Chitin and Glucan Synthesis by Cell Wall Synthase Inhibitors
Chantal Fernandes et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Macrophage Reporter Cell Assay for Screening Immunopharmacological Activity of Cell Wall-Active Antifungals
Russell E. Lewis et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Update on antifungal resistance in Aspergillus and Candida
M. C. Arendrup
CLINICAL MICROBIOLOGY AND INFECTION (2014)
Species distribution and in vitro antifungal susceptibility profiles of yeast isolates from invasive infections during a Portuguese multicenter survey
I. Faria-Ramos et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2014)
FK520 interacts with the discrete intrahelical amino acids of multidrug transporter Cdr1 protein and acts as antagonist to selectively chemosensitize azole-resistant clinical isolates of Candida albicans
Shweta Nim et al.
FEMS YEAST RESEARCH (2014)
Epidemiology of candidaemia and invasive candidiasis. A changing face
Guillermo Quindos
REVISTA IBEROAMERICANA DE MICOLOGIA (2014)
Correction: Differential Adaptation of Candida albicans In Vivo Modulates Immune Recognition by Dectin-1
Mohlopheni J. Marakalala et al.
PLoS Pathogens (2014)
Elevated Chitin Content Reduces the Susceptibility of Candida Species to Caspofungin
Louise A. Walker et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Chromosome 5 Monosomy of Candida albicans Controls Susceptibility to Various Toxic Agents, Including Major Antifungals
Feng Yang et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Diagnosis and Treatment of Invasive Fungal Infections Focus on Liposomal Amphotericin B
Joao F. Lacerda et al.
CLINICAL DRUG INVESTIGATION (2013)
Determination of chitin content in fungal cell wall: An alternative flow cytometric method
Sofia Costa-de-Oliveira et al.
CYTOMETRY PART A (2013)
In Vitro Activities of Isavuconazole and Comparator Antifungal Agents Tested against a Global Collection of Opportunistic Yeasts and Molds
Michael A. Pfaller et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2013)
Reshuffling of Aspergillus fumigatus Cell Wall Components Chitin and β-Glucan under the Influence of Caspofungin or Nikkomycin Z Alone or in Combination
Patricia E. B. Verwer et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Elevated Cell Wall Chitin in Candida albicans Confers Echinocandin Resistance In Vivo
Keunsook K. Lee et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
A Recently Evolved Transcriptional Network Controls Biofilm Development in Candida albicans
Clarissa J. Nobile et al.
CELL (2012)
An alternative respiratory pathway on Candida krusei: implications on susceptibility profile and oxidative stress
Sofia Costa-de-Oliveira et al.
FEMS YEAST RESEARCH (2012)
Calcium-Activated-Calcineurin Reduces the In Vitro and In Vivo Sensitivity of Fluconazole to Candida albicans via Rta2p
Yu Jia et al.
PLOS ONE (2012)
An A643V Amino Acid Substitution in Upc2p Contributes to Azole Resistance in Well-Characterized Clinical Isolates of Candida albicans
Samantha J. Hoot et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Paradoxical Effect of Caspofungin against Candida Bloodstream Isolates Is Mediated by Multiple Pathways but Eliminated in Human Serum
Ryan K. Shields et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Candida krusei reservoir in a neutropaenia unit: molecular evidence of a foe?
E. Ricardo et al.
CLINICAL MICROBIOLOGY AND INFECTION (2011)
In vitro synergisms obtained by amphotericin B and voriconazole associated with non-antifungal agents against Fusarium spp
Tarcieli P. Venturini et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2011)
Recognition and Blocking of Innate Immunity Cells by Candida albicans Chitin
Hector M. Mora-Montes et al.
INFECTION AND IMMUNITY (2011)
Management of invasive fungal infections: a role for polyenes
Pranatharthi Chandrasekar
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Candidemia in Burn Patients: Figures and Facts
Ana Filipa Bastos Pedrosa et al.
JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE (2011)
An A643T Mutation in the Transcription Factor Upc2p Causes Constitutive ERG11 Upregulation and Increased Fluconazole Resistance in Candida albicans
Clemens J. Heilmann et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Novel FKS Mutations Associated with Echinocandin Resistance in Candida Species
Guillermo Garcia-Effron et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Chitin synthesis and fungal pathogenesis
Megan D. Lenardon et al.
CURRENT OPINION IN MICROBIOLOGY (2010)
Liposomal amphotericin B eradicates Candida albicans biofilm in a continuous catheter flow model
Marc Seidler et al.
FEMS YEAST RESEARCH (2010)
Regulation of multidrug resistance in pathogenic fungi
Joachim Morschhaeuser
FUNGAL GENETICS AND BIOLOGY (2010)
Wild-Type MIC Distributions and Epidemiological Cutoff Values for the Triazoles and Six Aspergillus spp. for the CLSI Broth Microdilution Method (M38-A2 Document)
A. Espinel-Ingroff et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2010)
Correlating Echinocandin MIC and Kinetic Inhibition of fks1 Mutant Glucan Synthases for Candida albicans: Implications for Interpretive Breakpoints
Guillermo Garcia-Effron et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Effect of Candida glabrata FKS1 and FKS2 Mutations on Echinocandin Sensitivity and Kinetics of 1,3-β-D-Glucan Synthase: Implication for the Existing Susceptibility Breakpoint
Guillermo Garcia-Effron et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Oral nystatin prophylaxis and neonatal fungal infections
A. Howell et al.
ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION (2009)
Clinical Practice Guidelines for the Management of Candidiasis: 2009 Update by the Infectious Diseases Society of America
Peter G. Pappas et al.
CLINICAL INFECTIOUS DISEASES (2009)
Efflux-Mediated Antifungal Drug Resistance
Richard D. Cannon et al.
CLINICAL MICROBIOLOGY REVIEWS (2009)
Hidden killers: persistence of opportunistic fungal pathogens in the human host
Christophe d'Enfert
CURRENT OPINION IN MICROBIOLOGY (2009)
Antifungal drug resistance mechanisms
Javier Peman et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2009)
Ibuprofen reverts antifungal resistance on Candida albicans showing overexpression of CDR genes
Elisabete Ricardo et al.
FEMS YEAST RESEARCH (2009)
Antifungal drug resistance mechanisms in fungal pathogens from the perspective of transcriptional gene regulation
Dominique Sanglard et al.
FEMS YEAST RESEARCH (2009)
Comparative pharmacodynamic interaction analysis between ciprofloxacin, moxifloxacin and levofloxacin and antifungal agents against Candida albicans and Aspergillus fumigatus
Theodouli Stergiopoulou et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
The alternative oxidase of Candida albicans causes reduced fluconazole susceptibility
Lan Yan et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
In vitro activity of isavuconazole against Trichosporon, Rhodotorula, Geotrichum, Saccharomyces and Pichia species
George R. Thompson et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Hsp90 Governs Echinocandin Resistance in the Pathogenic Yeast Candida albicans via Calcineurin
Sheena D. Singh et al.
PLOS PATHOGENS (2009)
ABC Transporter Cdr1p Contributes More than Cdr2p Does to Fluconazole Efflux in Fluconazole-Resistant Candida albicans Clinical Isolates
Ann R. Holmes et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Propofol lipidic infusion promotes resistance to antifungals by reducing drug input into the fungal cell
Sofia Costa-de-Oliveira et al.
BMC MICROBIOLOGY (2008)
The changing epidemiology of invasive Candidiasis - Candida glabrata and Candida krusei as the leading causes of candidemia in hematologic malignancy
Ray Hachem et al.
CANCER (2008)
Resistance to antifungal agents: Mechanisms and clinical impact
Zeina A. Kanafani et al.
CLINICAL INFECTIOUS DISEASES (2008)
Stress, drugs, and evolution: The role of cellular signaling in fungal drug resistance
Leah E. Cowen et al.
EUKARYOTIC CELL (2008)
A gain-of-function mutation in the transcription factor Upc2p causes Upregulation of ergosterol biosynthesis genes and increased Fluconazole resistance in a clinical Candida albicans isolate
Nico Dunkel et al.
EUKARYOTIC CELL (2008)
A first Portuguese epidemiological survey of fungaemia in a university hospital
S. Costa-de-Oliveira et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2008)
Clinical relevance of resistance to antifungals
Juan Luis Rodriguez-Tudela et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2008)
Rifampicin induces MDR1 expression in Candida albicans
Miriam Vogel et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Mutations in the multi-drug resistance regulator MRR1, followed by loss of heterozygosity, are the main cause of MDR1 overexpression in fluconazole-resistant Candida albicans strains
Nico Dunkel et al.
MOLECULAR MICROBIOLOGY (2008)
An isochromosome confers drug resistance in vivo by amplification of two genes, ERG11 and TAC1
Anna Selmecki et al.
MOLECULAR MICROBIOLOGY (2008)
The evolution of fungal drug resistance: modulating the trajectory from genotype to phenotype
Leah E. Cowen
NATURE REVIEWS MICROBIOLOGY (2008)
Overcoming multidrug resistance of small-molecule therapeutics through conjugation with releasable octaarginine transporters
Elena A. Dubikovskaya et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Stimulation of chitin synthesis rescues Candida albicans from echinocandins
Louise A. Walker et al.
PLOS PATHOGENS (2008)
Overcoming drug resistance induced by P-glycoprotein on lymphocytes in patients with refractory rheumatoid arthritis
S. Tsujimura et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
In vitro interactions between tacrolimus and Azoles against Candida albicans determined by different methods
Shujuan Sun et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Paradoxical growth effects of the echinocandins caspofungin and micafungin, but not of anidulafungin, on clinical isolates of Candida albicans and C-dubliniensis
M. Fleischhacker et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2008)
Posaconazole: A broad-spectrum triazole antifungal agent
Vijayalakshmi Nagappan et al.
CLINICAL INFECTIOUS DISEASES (2007)
cis-acting elements within the Candida albicans ERG11 promoter mediate the azole response through transcription factor Upc2p
Brian G. Oliver et al.
EUKARYOTIC CELL (2007)
Accidental virulence, cryptic pathogenesis, Martians, lost hosts, and the pathogenicity of environmental microbes
Arturo Casadevall et al.
EUKARYOTIC CELL (2007)
The transcription factor Mrr1p controls expression of the MDR1 efflux pump and mediates multidrug resistance in Candida albicans
Joachim Morschhaeuser et al.
PLOS PATHOGENS (2007)
Critical roles for a genetic code alteration in the evolution of the genus Candida
Raquel M. Silva et al.
EMBO JOURNAL (2007)
A Genetic Code Alteration Is a Phenotype Diversity Generator in the Human Pathogen Candida albicans
Isabel Miranda et al.
PLOS ONE (2007)
Genotypic evolution of azole resistance mechanisms in sequential Candida albicans isolates
Alix Coste et al.
EUKARYOTIC CELL (2007)
Candida albicans drug resistance -: another way to cope with stress
Richard D. Cannon et al.
MICROBIOLOGY-SGM (2007)
Antifungal use in intensive care units
Elisabeth Meyer et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Harnessing calcineurin as a novel anti-infective agent against invasive fungal infections
William J. Steinbach et al.
NATURE REVIEWS MICROBIOLOGY (2007)
Resistance to echinocandin-class antifungal drugs
David S. Perlin
DRUG RESISTANCE UPDATES (2007)
Serum differentially alters the antifungal properties of echinocandin drugs
Padmaja Paderu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Candidemia in immunocompromised and immunocompetent critically ill patients: a prospective comparative study
G. Dimopoulos et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2007)
Risk of resistance associated with fluconazole prophylaxis: Systematic review
Luc P. Brion et al.
JOURNAL OF INFECTION (2007)
In vivo efficacy of anidulafungin and caspofungin against Candida glabrata and association with in vitro potency in the presence of sera
Nathan P. Wiederhold et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Candida albicans and Candida dubliniensis respond differently to echinocandin antifungal agents in vitro
Mette D. Jacobsen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
The PKC, HOG and Ca2+ signalling pathways co-ordinately regulate chitin synthesis in Candida albicans
Carol A. Munro et al.
MOLECULAR MICROBIOLOGY (2007)
Aspirin and ibuprofen enhance pyrazinamide treatment of murine tuberculosis
Sean T. Byrne et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Epidemiology of invasive candidiasis: a persistent public health problem
M. A. Pfaller et al.
CLINICAL MICROBIOLOGY REVIEWS (2007)
Human pharmacogenomic variations and their implications for antifungal efficacy
Joseph Meletiadis et al.
CLINICAL MICROBIOLOGY REVIEWS (2006)
Escape of Candida from caspofungin inhibition at concentrations above the MIC (Paradoxical effect) accomplished by increased cell wall chitin;: Evidence for β-1,6-glucan synthesis inhibition by caspofungin
David A. Stevens et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Modulation of multidrug resistance efflux pump activity to overcome chemoresistance in cancer
Szabolcs Modok et al.
CURRENT OPINION IN PHARMACOLOGY (2006)
Candida albicans and Candida glabrata clinical isolates exhibiting reduced echinocandin susceptibility
Santosh Katiyar et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Aneuploidy and isochromosome formation in drug-resistant Candida albicans
Anna Selmecki et al.
SCIENCE (2006)
Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: A multi-institutional study
Kevin W. Garey et al.
CLINICAL INFECTIOUS DISEASES (2006)
A mutation in Tac1p, a transcription factor regulating CDR1 and CDR2, is coupled with loss of heterozygosity at chromosome 5 to mediate antifungal resistance in Candida albicans
A Coste et al.
GENETICS (2006)
Modulator-induced interference in functional cross talk between the substrate and the ATP sites of human P-glycoprotein
N Maki et al.
BIOCHEMISTRY (2006)
Inhibition of Candida parapsilosis mitochondrial respiratory pathways enhances susceptibility to caspofungin
G Chamilos et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Human albumin promotes germination, hyphal growth and antifungal resistance by Aspergillus fumigatus
AG Rodrigues et al.
MEDICAL MYCOLOGY (2005)
Potent synergic effect between ibuprofen and azoles on Candida resulting from blockade of efflux pumps as determined by FUN-1 staining and flow cytometry
C Pina-Vaz et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
Specific substitutions in the echinocandin target Fks1p account for reduced susceptibility of rare laboratory and clinical Candida sp isolates
S Park et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
An update on antifungal targets and mechanisms of resistance in Candida albicans
RA Akins
MEDICAL MYCOLOGY (2005)
The G protein-coupled receptor Gpr1 and the Gα protein Gpa2 act through the cAMP-protein kinase a pathway to induce morphogenesis in candida albicans
MM Maidan et al.
MOLECULAR BIOLOGY OF THE CELL (2005)
Reassessment of the in vitro synergistic effect of fluconazole with the non-steroidal anti-inflammatory agent ibuprofen against Candida albicans
R Arai et al.
MYCOSES (2005)
Surface-active fungicidal D-peptide inhibitors of the plasma membrane proton pump that block azole resistance
BC Monk et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
The role of antifungal susceptibility testing in the therapy of candidiasis
DR Hospenthal et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2004)
Three-dimensional models of wild-type and mutated forms of cytochrome P450 14α-sterol demethylases from Aspergillus fumigatus and Candida albicans provide insights into posaconazole binding
L Xiao et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Development and characterization of an in vivo central venous catheter Candida albicans biofilm model
D Andes et al.
INFECTION AND IMMUNITY (2004)
Role of Candida albicans transcription factor Upc2p in drug resistance and sterol metabolism
PM Silver et al.
EUKARYOTIC CELL (2004)
The calcineurin target, crz1, functions in azole tolerance but is not required for virulence of Candida albicans
C Onyewu et al.
INFECTION AND IMMUNITY (2004)
TAC1, transcriptional activator of CDR genes, is a new transcription factor involved in the regulation of candida albicans ABC transporters CDR1 and CDR2
AT Coste et al.
EUKARYOTIC CELL (2004)
In-vitro activity of nikkomycin Z alone and in combination with polyenes, triazoles or echinocandins against Aspergillus fumigatus
LT Ganesan et al.
CLINICAL MICROBIOLOGY AND INFECTION (2004)
Homozygosity at the MTL locus in clinical strains of Candida albicans:: karyotypic rearrangements and tetraploid formation
M Legrand et al.
MOLECULAR MICROBIOLOGY (2004)
Management of candida species infections in critically ill patients
P Eggimann et al.
LANCET INFECTIOUS DISEASES (2003)
Cyclic AMP signaling pathway modulates susceptibility of Candida species and Saccharomyces cerevisiae to antifungal azoles and other sterol biosynthesis inhibitors
P Jain et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Genome-wide expression profiling of the response to polyene, pyrimidine, azole, and echinocandin antifungal agents in Saccharomyces cerevisiae
AK Agarwal et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
The echinocandin antifungals: an overview of the pharmacology, spectrum and clinical efficacy
NP Wiederhold et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2003)
Candida albicans mutations in the ergosterol biosynthetic pathway and resistance to several antifungal agents
D Sanglard et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Mechanism of fluconazole resistance in Candida albicans biofilms:: Phase-specific role of efflux pumps and membrane sterols
PK Mukherjee et al.
INFECTION AND IMMUNITY (2003)
Antifungal agents: mechanisms of action
FC Odds et al.
TRENDS IN MICROBIOLOGY (2003)
Calcineurin A of Candida albicans:: involvement in antifungal tolerance, cell morphogenesis and virulence
D Sanglard et al.
MOLECULAR MICROBIOLOGY (2003)
Genome-wide expression profile analysis reveals coordinately regulated genes associated with stepwise acquisition of azole resistance in Candida albicans clinical isolates
PD Rogers et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Drug resistance is not directly affected by mating type locus zygosity in Candida albicans
C Pujol et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Relationships between respiration and susceptibility to azole antifungals in Candida glabrata
S Brun et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Recent trends in the epidemiology of invasive mycoses
TA Clark et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2002)
Resistance mechanisms in clinical isolates of Candida albicans
TC White et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Investigation of multidrug efflux pumps in relation to fluconazole resistance in Candida albicans biofilms
G Ramage et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2002)
Homozygosity at the Candida albicans MTL locus associated with azole resistance
TR Rustad et al.
MICROBIOLOGY-SGM (2002)
Heterogeneous mechanisms of azole resistance in Candida albicans clinical isolates from an HIV-infected patient on continuous fluconazole therapy for oropharyngeal candidosis
M Martinez et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2002)
Prevalence of molecular mechanisms of resistance to azole antifungal agents in Candida albicans strains displaying high-level fluconazole resistance isolated from human immunodeficiency virus-infected patients
S Perea et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Risk factors for candidal bloodstream infections in surgical intensive care unit patients: The NEMIS Prospective Multicenter Study
HM Blumberg et al.
CLINICAL INFECTIOUS DISEASES (2001)
A randomized, double-blind comparative trial evaluating the safety of liposomal amphotericin B versus amphotericin B lipid complex in the empirical treatment of febrile neutropenia
JR Wingard et al.
CLINICAL INFECTIOUS DISEASES (2000)
Fluconazole plus cyclosporine:: A fungicidal combination effective against experimental endocarditis due to Candida albicans
O Marchetti et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
A family of drug transporters: The multidrug resistance-associated proteins
P Borst et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Drug interaction studies of a glucan synthase inhibitor (LY 303366) and a chitin synthase inhibitor (nikkomycin Z) for inhibition and killing of fungal pathogens
DA Stevens
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Share Paper
